The pharmaceutical company's consolidated net profit tumbled 63.6% to Rs 3.68 crore despite of 12.54% increase in revenue from operations to Rs 2,204.22 crore in Q3 FY25 over Q3 FY24.
4. The aforesaid action of the AO dated 29.03.2022 passed u/s.147/143 (3) of the Act has been interfered by the Ld.PCIT u/s.263 of the Act holding it to be erroneous as well as prejudicial to the ...